The Effect of Dienogest vs. Norethindrone Acetate Treatment in Endometriosis

Sponsor
Uludag University
Study ID
NCT05476172
Status
Completed

Conditions

Eligibility Criteria

Sex
FEMALE
Age
18 Years - 40 Years
Healthy Volunteers
Not accepted

Interventions

  • Dienogest Pill — DRUG
    The effect of dienogest on endometriosis pain symptoms.
  • Norethindrone Acetate — DRUG
    The effect of Norethindrone Acetateon endometriosis pain symptoms.

Study Details

This randomized controlled study aims to investigate the efficiency of medical treatment modalities in endometriosis patients. The study protocol involves two arms. (Dienogest Group and Noretindrone Acetate Group). The patients diagnosed with endometriosis are randomized depending on their protocol ids. The Dienogest group is prescribed 5 mg dienogest per day and neta group is prescribed 5 mg neta per day. The pain scores will be analyzed six months and twelve months after treatment.

Key Dates

Start date
Apr 1, 2021
Status verified
Jul 2023
Primary completion
May 30, 2023
Completion
Jun 30, 2023

Study Design

Enrollment
70 participants (actual)
Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT

Arms

  • Active Comparator: Dienogest
    Patients with endometriosis are prescribed dienogest for treatment.
  • Active Comparator: Norethindrone Acetate
    Patients with endometriosis are prescribed Norethindrone Acetate for treatment.

Primary Outcome Measure

Chronic Pelvic Pain [ Time Frame: Change from Baseline Score at 6 months ]

Related Studies